Status:
SUSPENDED
Telemonitoring of Patients With Acute Coronary Syndrome
Lead Sponsor:
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18-80 years
Brief Summary
It is planned to enroll 950 patients in an open, prospective, randomized study to assess the impact of telemonitoring on the development of clinical events and improve the quality of life of patients ...
Detailed Description
Purpose of the study: to study the effect of telemonitoring on the development of clinical events and improving the quality of life of patients with ACS. Research objectives: 1. Improving the effect...
Eligibility Criteria
Inclusion
- Signed informed consent;
- Age 18 - 80 years old.
- Diagnosis:
- Acute myocardial infarction (I21.0, I21.1, I21.2, I21.3, I21.4, I21.9)
- Unstable angina (I20.0) Recurrent myocardial infarction (I22.0, I22.1, I22.8, I22.9)
Exclusion
- Lack of technical equipment to connect to remote monitoring programs;
- Severe cognitive dysfunction - dementia leading to maladjustment in everyday life;
- Mental illness in the acute stage;
- Oncological diseases requiring radiation and chemotherapy during the period of this study, as well as the corresponding stages of T3-4N2-3M1;
- Lack of technical ability to take part in telemonitoring (do not have the skills to work on a smartphone, computer, tablet, there is no appropriate technical means);
- Participation in other clinical studies to assess the effectiveness of pharmacological drugs;
- Infection with SARS-CoV-2 with laboratory confirmation during the period of this study;
- Acute coronary syndrome that developed in the hospital after surgery / intervention;
- The emergence during observation of the need for surgical (not counting myocardial revascularization) or chemotherapy treatment;
- Severe trauma (including craniocerebral) impeding observation according to the study protocol.
Key Trial Info
Start Date :
April 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
950 Patients enrolled
Trial Details
Trial ID
NCT04862026
Start Date
April 29 2021
End Date
June 1 2025
Last Update
April 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City Clinical Hospital No. 13 of the Moscow City Health Department
Moscow, Russia, 115280